Berberine Suppresses Neuroinflammatory Responses through AMP-Activated Protein Kinase Activation in BV-2 Microglia
Therapies are prescribed and/or recommended following a clinical evaluation of your labs and health history, where appropriate
Competing Interests Professor Melanie Davies has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Abbvie, Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma Regeneron, GSK and EktaH and as a speaker for AstraZeneca and Boehringer Ingelheim
Common maintenance approaches include staying at the dose where you stabilized (often 1.0 to 1.7 mg), reducing by one dose level from your peak (e.g., from 2.4 mg to 1.7 mg), or finding the minimum dose that prevents weight regain while minimizing side effects
doi: 10.4161/cc.10.10.15703 231 JonesRARobinsonTJLiuJCShresthaMVoisinVJuYet al
We use a baby needle, smaller than many acupuncture needles used in our own clinic